Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Bipolar disorders

Publikation: Bidrag til tidsskriftReviewpeer review

  1. A nation-wide population-based longitudinal study mapping physical diseases in patients with bipolar disorder and their siblings

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. A skewed perspective - A reply to Kovvuru et al

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  3. Hippocampal subfield morphology in monozygotic twins discordant for affective disorders

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Daily mobility patterns in patients with bipolar disorder and healthy individuals

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Roger S McIntyre
  • Michael Berk
  • Elisa Brietzke
  • Benjamin I Goldstein
  • Carlos López-Jaramillo
  • Lars Vedel Kessing
  • Gin S Malhi
  • Andrew A Nierenberg
  • Joshua D Rosenblat
  • Amna Majeed
  • Eduard Vieta
  • Maj Vinberg
  • Allan H Young
  • Rodrigo B Mansur
Vis graf over relationer

Bipolar disorders are a complex group of severe and chronic disorders that includes bipolar I disorder, defined by the presence of a syndromal, manic episode, and bipolar II disorder, defined by the presence of a syndromal, hypomanic episode and a major depressive episode. Bipolar disorders substantially reduce psychosocial functioning and are associated with a loss of approximately 10-20 potential years of life. The mortality gap between populations with bipolar disorders and the general population is principally a result of excess deaths from cardiovascular disease and suicide. Bipolar disorder has a high heritability (approximately 70%). Bipolar disorders share genetic risk alleles with other mental and medical disorders. Bipolar I has a closer genetic association with schizophrenia relative to bipolar II, which has a closer genetic association with major depressive disorder. Although the pathogenesis of bipolar disorders is unknown, implicated processes include disturbances in neuronal-glial plasticity, monoaminergic signalling, inflammatory homoeostasis, cellular metabolic pathways, and mitochondrial function. The high prevalence of childhood maltreatment in people with bipolar disorders and the association between childhood maltreatment and a more complex presentation of bipolar disorder (eg, one including suicidality) highlight the role of adverse environmental exposures on the presentation of bipolar disorders. Although mania defines bipolar I disorder, depressive episodes and symptoms dominate the longitudinal course of, and disproportionately account for morbidity and mortality in, bipolar disorders. Lithium is the gold standard mood-stabilising agent for the treatment of people with bipolar disorders, and has antimanic, antidepressant, and anti-suicide effects. Although antipsychotics are effective in treating mania, few antipsychotics have proven to be effective in bipolar depression. Divalproex and carbamazepine are effective in the treatment of acute mania and lamotrigine is effective at treating and preventing bipolar depression. Antidepressants are widely prescribed for bipolar disorders despite a paucity of compelling evidence for their short-term or long-term efficacy. Moreover, antidepressant prescription in bipolar disorder is associated, in many cases, with mood destabilisation, especially during maintenance treatment. Unfortunately, effective pharmacological treatments for bipolar disorders are not universally available, particularly in low-income and middle-income countries. Targeting medical and psychiatric comorbidity, integrating adjunctive psychosocial treatments, and involving caregivers have been shown to improve health outcomes for people with bipolar disorders. The aim of this Seminar, which is intended mainly for primary care physicians, is to provide an overview of diagnostic, pathogenetic, and treatment considerations in bipolar disorders. Towards the foregoing aim, we review and synthesise evidence on the epidemiology, mechanisms, screening, and treatment of bipolar disorders.

Udgave nummer10265
Sider (fra-til)1841-1856
Antal sider16
StatusUdgivet - 5 dec. 2020

Bibliografisk note

Copyright © 2020 Elsevier Ltd. All rights reserved.

ID: 61529517